Anebulo Pharmaceuticals, Inc. (ANEB)

NASDAQ: ANEB · Real-Time Price · USD

0.4347

-0.0383 (-8.10%)

At close: Feb 23, 2026, 4:00 PM EST

0.4237

-0.0110 (-2.53%)

After-hours: Feb 23, 2026, 7:07 PM EST

Anebulo Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	18	59	71	60	121	159
Market Cap Growth	-56.46%	-16.43%	17.53%	-50.38%	-23.75%	-
Enterprise Value	9	46	66	46	105	159
Last Close Price	0.43	1.44	2.73	2.35	5.20	6.82
PB Ratio	2.25	5.08	18.57	5.68	8.06	7.44
P/TBV Ratio	2.23	5.08	18.57	5.68	8.06	7.44
Net Debt / Equity Ratio	-1.14	-1.00	-0.81	-1.06	-0.97	-0.93
Quick Ratio	6.12	23.99	11.87	10.52	28.39	82.71
Current Ratio	6.24	24.53	13.46	10.92	30.40	89.61
Return on Equity (ROE)	-69.69%	-109.69%	-113.80%	-91.42%	-37.42%	-249.85%
Return on Assets (ROA)	-45.04%	-71.09%	-65.97%	-54.05%	-22.93%	-18.30%
Return on Capital Employed (ROCE)	-114.70%	-79.10%	-217.90%	-111.20%	-45.30%	-16.90%
Earnings Yield	-45.00%	-14.34%	-11.58%	-19.48%	-5.62%	-19.00%
Buyback Yield / Dilution	-55.97%	-30.97%	-2.98%	-7.41%	-71.49%	-13.44%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q